With FDA nod, Tonix's Tonmya becomes first new fibromyalgia treatment in more than 16 years

Fierce Pharma·Aug 15

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Tonix's Tonmya has received FDA approval for the treatment of fibromyalgia, reportedly the first new therapy for the condition in over 15 years. The approval has been confirmed by multiple outlets, with some noting it is the first new fibromyalgia treatment in more than 16 years. The treatment is described as a sublingual formulation, and its commercial potential is being assessed ahead of a planned launch.

Full coverage

Tonix Pharma's Drug Gets FDA Nod For Chronic Pain Condition, First New Therapy In Over 15 Years

Yahoo Finance·Aug 18

Tonix Pharma Scores Best Day Since March On Hopes For First New Fibromyalgia Drug Approval in 16 Years; Retail’s Optimistic

Stocktwits·Aug 13

Alzheimer’s Therapy Is Coming to the Home With FDA Approval of Injectable Eisai, Biogen Drug

MedCity News·Sep 2

Tonix Pharmaceutical’s Tonmya approved: first fibromyalgia drug in 15 years

Proactive financial news·Aug 19

View original report at Fierce Pharma ↗

Fetching the latest headlines…

With FDA nod, Tonix's Tonmya becomes first new fibromyalgia treatment in more than 16 years

Full coverage

Tonix Pharma's Drug Gets FDA Nod For Chronic Pain Condition, First New Therapy In Over 15 Years

Tonix's sublingual treatment approved for fibromyalgia

FDA Greenlights Tonmya for Fibromyalgia Treatment - MPR

Tonix: Assessing Tonmya's Commercial Potential Ahead Of Q4 2025 Launch

TNXP: Tonmya™ Approved by FDA…

Tonix Pharma Scores Best Day Since March On Hopes For First New Fibromyalgia Drug Approval in 16 Years; Retail’s Optimistic

Alzheimer’s Therapy Is Coming to the Home With FDA Approval of Injectable Eisai, Biogen Drug

Tonix Pharmaceutical’s Tonmya approved: first fibromyalgia drug in 15 years